N-(6-methyl-1,3-benzothiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide
Chemical Structure Depiction of
N-(6-methyl-1,3-benzothiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide
N-(6-methyl-1,3-benzothiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide
Compound characteristics
| Compound ID: | G857-0121 |
| Compound Name: | N-(6-methyl-1,3-benzothiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide |
| Molecular Weight: | 485.63 |
| Molecular Formula: | C23 H27 N5 O3 S2 |
| Smiles: | Cc1ccc2c(c1)sc(NC(CSC1C3CCCC=3N(CCN3CCOCC3)C(N=1)=O)=O)n2 |
| Stereo: | ACHIRAL |
| logP: | 2.9477 |
| logD: | 2.8788 |
| logSw: | -3.2307 |
| Hydrogen bond acceptors count: | 9 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 69.266 |
| InChI Key: | VLSQHJQCGMXATP-UHFFFAOYSA-N |